Vivani Medical, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0 | $0 | — | — | — |
| Cost of revenue | — | — | — | — | $130,000 |
| Gross profit | — | — | — | — | $130,000 |
| Research and development | $18.1M | $15.7M | $17.0M | $14.2M | $11.0M |
| Operating expenses | $27.6M | $24.7M | $27.0M | $21.2M | $13.3M |
| Operating income | -$27.6M | -$24.7M | -$27.0M | -$21.2M | -$13.3M |
| Pretax income | -$26.6M | -$23.5M | — | — | — |
| Income tax expense | — | $2,000 | — | — | — |
| Net income | -$26.6M | -$23.5M | -$25.7M | -$13.9M | -$12.8M |
| Balance Sheet | |||||
| Cash and equivalents | $16.2M | $18.4M | $20.7M | $45.1M | $69.6M |
| Current assets | $17.9M | $20.4M | $23.1M | $47.5M | $2.5M |
| Total assets | $39.4M | $41.6M | $45.8M | $51.1M | $5.5M |
| Current liabilities | $6.6M | $6.0M | $5.7M | $6.8M | $2.1M |
| Total liabilities | $23.7M | $24.0M | $25.0M | $6.8M | $3.0M |
| Stockholders' equity | $15.7M | $17.6M | $20.8M | $44.3M | $2.5M |
| Cash Flow Statement | |||||
| Cash from operations | -$24.3M | -$20.8M | -$23.7M | -$18.8M | -$11.0M |
| Depreciation and amortization | $424,000 | $400,000 | $357,000 | $381,000 | $345,000 |
| Stock-based compensation | $1.5M | $1.6M | $1.9M | $1.3M | $1.7M |
| Capital expenditure | $1.2M | $556,000 | $887,000 | $338,000 | $572,000 |
| Free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M | -$11.5M |
| Impairments | — | — | — | — | $700,000 |
Shares outstanding 86.2M · Free float 31.0%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.